跳至主要内容
临床试验/NCT04757246
NCT04757246撤回不适用

RESPECT Heart Failure- RESpiratory Pattern Evaluation in Clinical Trials for HF

WakeMed Health and Hospitals2 个研究点 分布在 1 个国家开始时间: 2022年10月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Measuring FEV1/FVC as a ratio

研究概览

简要总结

The goal is to evaluate the trends in MouthLab parameters (respiration rate, temperature, pulse rate, electrocardiogram rhythm, blood pressure, oxygen saturation heart rate and basic lung function measures) in patients with decompensated heart failure and how these measurements change in response to decongestion. The research will test the ability of the MouthLab device to predict clinical decompensation in patients with known heart failure and to reduce the number of hospital readmissions based on the treatment guided by MouthLab device data.

详细描述

Heart failure (HF) is becoming increasingly recognized with an estimated worldwide prevalence of >37.7 million individuals. In the United States alone, there are over 5 million patients with HF which is expected to increase to over 8 million by 2030. Despite advances in medical therapies and technology, HF remains the leading cause of hospitalization among adults and the elderly. By 2030, the medical costs of HF are expected to rise from $20.9 billion to $53.1 billion, with nearly 80% of the projected increased expenses attributes to hospitalization costs. As such, it is imperative to develop new technologies and treatment options to impact the HF epidemic.

The majority of HF hospital admissions are due to volume overload. Stiffened and/or weakened myocardium predisposes patients to the accumulation of extracellular fluid resulting in increased intracardiac filling pressures and symptoms of congestion (edema, dyspnea and orthopnea). Accurate assessment of a patient's volume status remains clinically challenging at times. While there have been technological advances in the outpatient monitoring of volume status through thoracic impedance and pulmonary artery pressure monitoring, there are no validated, non-implantable options for monitoring volume status outside of the physical exam.

Aidar Health's MouthLab device is a non-invasive, hand-held, home monitoring tool that measures multiple medical parameters such as - Temperature, Blood Pressure, Heart Rate, Heart Rate Variability, Pulse Rate, SpO2, single-lead ECG, Respiratory Rate, Breathing Pattern/Respiratory Flow Cycle Morphology, and basic lung functions (FEV1, FVC, FEV1/FVC, PEF) in 30 seconds.

The investigators believe that the MouthLab device holds the potential to identify changes in volume status through measurements such as pulse rate, oxygen saturation, respiratory flow and lung function and accurately predict decompensation in patients with chronic HF. The investigators propose the following outline of clinical studies to evaluate the utility of the MouthLab device in HF.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Measuring FEV1/FVC as a ratio

时间窗: 6 months

Determining Lung Function

Evaluate trends of temperature measured in Fahrenheit

时间窗: 6 months

Temperature

Evaluate trends of respiration rate per minute

时间窗: 6 months

Respiration rate measured by breaths taken per minute

Aidar Questionnaire to Evaluate Patient Perception of Heart Failure

时间窗: 6 months

The Aidar Questionnaire will be used to determine patient perception of severity of heart failure.

Evaluating the QRS complex on electrocardiogram in milliseconds

时间窗: 6 months

QRS complex will be measured to determine heart rhythm

Evaluating the T wave on electrocardiogram in milliseconds

时间窗: 6 months

T wave will be measured to determine heart rhythm

Evaluate trends of blood pressure measured in mm/Hg

时间窗: 6 months

Blood pressure

Evaluate trends of blood oxygen saturation (SpO2) in percentage

时间窗: 6 months

blood oxygen saturation (SpO2)

Evaluate trends of pulse rate per minute

时间窗: 6 month

Pulse rate

Evaluating the P wave of electrocardiogram in milliseconds

时间窗: 6 months

P wave on electrocardiogram will be measured to determine heart rhythm

Measuring FEV1 (Forced Expiratory Volume) in Liters

时间窗: 6 months

Determining Lung Function

Measuring FVC (Forced Vital Capacity) in Liters

时间窗: 6 months

Determining Lung Function

Measuring PEF (Peak Expiratory Flow) in Liters/second

时间窗: 6 months

Determining Lung Function

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stuart Russell, M.D.

Principal Investigator

WakeMed Health and Hospitals

研究点 (2)

Loading locations...

相似试验